Identification of a novel functional androgen response element within hPar1 promoter: Implications to prostate cancer progression

FASEB Journal

Volumn 19, Issue 1, 2005, Pages 62-72

  Salah, Zaidoun ^a   Maoz, Myriam ^a   Cohen, Irit ^a   Pizov, Galina ^a   Pode, Dov ^a   Runge, Marschall S ^b   Bar Shavit, Rachel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen hormone; PAR1; Prostate carcinoma; Protease activated receptor 1

Indexed keywords

ANDROSTANOLONE; ANTIANDROGEN; LUCIFERASE; OLIGONUCLEOTIDE; PROTEINASE ACTIVATED RECEPTOR 1;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER REGRESSION; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANDROGENS; ANTINEOPLASTIC AGENTS, HORMONAL; BASE COMPOSITION; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DISEASE PROGRESSION; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTOR, PAR-1; RESPONSE ELEMENTS;

TRIXIS;

EID: 11244255408     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2386com     Document Type: Article

References (49)

1. Cunha, G. R., Donjacour, A. A., Cooke, P. S., Mee, S., Bigsby, R. M., Higgins, S. J., and Sugimura, Y. (1987) The endocrinology and developmental biology of the prostate. Endocr. Rev. 8, 338-362
2. Jin, B., Conway, A. J., and Handelsman, D. J. (2001) Effects of androgen deficiency and replacement on prostate zonal volumes. Clin. Endocrinol. (Oxford) 54, 437-445
3. Kurita, T., Wang, Y. Z., Donjacour, A. A., Zhao, C., Lydon, J. P., O'Malley, B. W., Isaacs, J. T., Dahiya, R., and Cunha, G. R. (2001) Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ. 8, 192-200
4. Gelmann, E. P. (2002) Molecular biology of the androgen receptor. J. Clin. Oncol. 20, 3001-3015
5. Grossmann, M. E., Huang, H., and Tindall, D. J. (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93, 1687-1697
6. Feldman, B. J., and Feldman, D. (2001) The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34-45
7. Navarro, D., Luzardo, O. P., Fernandez, L., Chesa, N., and Diaz-Chico, B. N. (2002) Transition to androgen-independence in prostate cancer. J. Steroid Biochem. Mol. Biol. 81, 191-201
8. Ham, J., Thomson, A., Needham, M., Webb, P., and Parker, M. (1988) Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res. 16, 5263-5276
9. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., and Bar-Shavit, R. (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909-914
10. Even-Ram, S. C., Maoz, M., Pokroy, E., Reich, R., Katz, B. Z., Gutwein, P., Altevogt, P., and Bar-Shavit, R. (2001) Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the α vβ 5 integrin. J. Biol. Chem. 276, 10952-10962
11. Henrikson, K. P., Salazar, S. L., Fenton II, J. W., and Pentecost, B. T. (1999) Role of thrombin receptor in breast cancer invasiveness. Br. J. Cancer 79, 401-406
12. Rudroff, C., Schafberg, H., Nowak, G., Weinel, R., Scheele, J., and Kaufmann, R. (1998) Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2). Pancreas 16, 189-194
13. Nierodzik, M. L., Chen, K., Takeshita, K., Li J. J., Huang, Y. Q., Feng, X. S., D'Andrea, M. R., Andrade-Gordon, P., and Karpatkin, S. (1998) Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92, 3694-3700
14. Darmoul, D., Gratio, V., Devaud, H., Lehy, T., and Laburthe, M. (2003) Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am. J. Pathol. 162, 1503-1513
15. Even-Ram, S. C., Grisaru-Granovsky, S., Pruss, D., Maoz, M., Salah, Z., Yong-Jun, Y., and Bar-Shavit, R. (2003) The pattern of expression of protease-activated receptors (PARs) during early trophoblast development. J. Pathol. 200, 47-52
16. Caunt, M., Huang, Y. Q., Brooks, P. C., and Karpatkin, S. (2003) Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J. Thromb. Haemost. 1, 2097-2102
17. Arisato, T., Sarker, K. P., Kawahara, K., Nakata, M., Hashiguchi, T., Osame, M., Kitajima, I., and Maruyama, I. (2003) The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells. Cell. Mol. Life Sci. 60, 1716-1724
18. Yin, Y. J., Salah, Z., Maoz, M., Ram, S. C., Ochayon, S., Neufeld, G., Katzav, S., and Bar-Shavit, R. (2003) Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J. 17, 163-174
19. Chay, C. H., Cooper, C. R., Gendernalik, J. D., Dhanasekaran, S. M., Chinnaiyan, A. M., Rubin, M. A., Schmaier, A. H., and Pienta, K. J. (2002) A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology 60, 760-765
20. Li, F., Baykal, D., Horaist, C., Van, C. N., Carr, B. N., Rao, G. N., and Runge, M. S. (1996) Cloning and identification of regulatory sequences of the human thrombin receptor gene. J. Biol. Chem. 271, 26320-26328
21. Schmidt, V. A., Vitale, E., and Bahou, W. F. (1996) Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor-2 gene. J. Biol. Chem. 271, 9307-9312
22. Wu, Y., Ruef, J., Rao, G. N., Patterson, C., and Runge, M. S. (1998) Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells. Biochem. J. 330, 1469-1474
23. Tellez, C., and Bar-Eli, M. (2003) Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22, 3130-3137
24. Herkert, O., Kuhl, H., Sandow, J., Busse, R., and Schini-Kerth, V. B. (2001) Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 104, 2826-2831
25. Andrews, N. C., and Faller, D. V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499
26. Roche, P. J., Hoare, S. A., and Parker, M. G. (1992) A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6, 2229-2235
27. Claessens, F., Celis, L., Peeters, B., Heyns, W., Verhoeven, G., and Rombauts, W. (1989) Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem. Biophys. Res. Commun. 164, 833-840
28. Riegman, P. H., Vlietstra, R. M., van der Korput, J. A., Brinkmann, A. O., and Trapman, J. (1991) The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5, 1921-1930
29. Crossley, M., Ludwig, M., Stowell, K. M., De Vos, P., Olek, K. and Brownlee, G. G. (1992) Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 257, 377-379
30. Ghyselinck, N. B., Dufaure, I., Lareyre, J. J., Rigaudiere, N., Mattei, M. G., and Dufaure, J. P. (1993) Structural organization and regulation of the gene for the androgen-dependent glutathione peroxidase-like protein specific to the mouse epididymis. Mol. Endocrinol. 7, 258-272
31. Rennie, P. S., Bruchovsky, M., Leco, K. J., Sheppard, P. C., McQueen, S. A., Cheng, H., Snoek, R., Hamel, A., Bock, M. E., and MacDonald, B. S. (1993) Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol. 7, 23-26
32. Fabre, S., Manin, M., Pailhoux, E., Veyssiere, G., and Jean, C. (1994) Indentification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferens. J. Biol. Chem. 269, 5857-5864
33. Gnanapragasam, V. J., Robson, C. N., Neal, D. E., and Leung, H. Y. (2002) Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21, 5069-5080
34. Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., and Keshet, E. (1998) Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 95, 10820-10825
35. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165
36. Patel, B. J., Pantuck, A. J., Zisman, A., Tsui, K. H., Paik, S. H., Caliliw, R., Sheriff, S., Wu, L., deKernion, J. B., Tso, C. L., and Belldegrun, A. S. (2000) CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. J. Urol. 164, 1420-1425
37. van Bokhoven, A., Varella-Garcia, M., Korch, C., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., and Lucia, M. S. (2003) Molecular characterization of human prostate carcinoma cell lines. Prostate 57, 205-225
38. Murtha, P., Tindall, D. J., and Young, C. Y. (1993) Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32, 6459-6464
39. Nelson, C. C., Hendy, S. C., Shukin, R. J., Cheng, H., Bruchovsky, N., Koop, B. F., and Rennie, P. S. (1999) Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol. Endocrinol. 13, 2090-2107
40. Glass, C. K., Rose, D. W., and Rosenfeld, M. G. (1997) Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232
41. Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., and Tung, L. (1996) Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10, 1167-1177
42. Smith, C. L., Onate, S. A., Tsai, M. J., and O'Malley, B. W. (1996) CREB-binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888
43. Visakorpi, T. (1999) New pieces to the prostate cancer puzzle. Nat. Med. 5, 264-265
44. Ruizeveld de Winter, J. A., Janssen, P. J., Sleddens, H. M., Verleun-Mooijman, M. C., Trapman, J., Brinkmann, A. O., Santerse, A. B., Schroder, F. H., and van der Kwast, T. H. (1994) Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am. J. Pathol. 144, 735-746
45. Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G., Klocker, H., and Culig, Z. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 58, 4640-4645
46. Prins, G. S., Sklarew, R. J., and Pertschuk, L. P. (1998) Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy. J. Urol. 159, 641-649
47. Gee, J. M., Robertson, J. F., Ellis, I. O., Nicholson, R. I., and Hurst, H. C. (1999) Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J. Pathol. 189, 514-520
48. Ruiz, M., Pettaway, C., Song, R., Stoeltzing, O., Ellis, L., and Bar-Eli, M. (2004) Activator protein 2α inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res. 64, 631-638
49. Ropponen, K. M., Kellokoski, J. K., Lipponen, P. K., Pietilainen, T., Eskelinen, M. J., Alhava, E. M., and Kosma, V. M. (1999) p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br. J. Cancer 81, 133-140